Literature DB >> 19428659

Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE.

Louis J Nkrumah1, Paul M Riegelhaupt, Pedro Moura, David J Johnson, Jigar Patel, Karen Hayton, Michael T Ferdig, Thomas E Wellems, Myles H Akabas, David A Fidock.   

Abstract

Quinine (QN) continues to be an important treatment option for severe malaria, however resistance to this drug has emerged in field isolates of the etiologic agent Plasmodium falciparum. Quantitative trait loci investigations of QN resistance have mapped three loci of this complex trait. Two coincide with pfcrt and pfmdr1, involved in resistance to chloroquine (CQ) and other quinoline-based antimalarials. A third locus on chromosome 13 contains the sodium-proton exchanger (pfnhe) gene. Previous studies have associated pfnhe polymorphisms with reduced QN sensitivity in culture-adapted field isolates. Here, we provide direct evidence supporting the hypothesis that pfnhe contributes to QN resistance. Using allelic exchange, we reduced pfnhe expression by introducing a truncated 3' untranslated region (UTR) from pfcrt into the endogenous pfnhe 3'UTR. Transfections were performed with 1BB5 and 3BA6 (both CQ- and QN-resistant) as well as GC03 (CQ- and QN-sensitive), all progenies of the HB3xDd2 genetic cross. RNA and protein analyses of the ensuing recombinant clones demonstrated a approximately 50% decrease in pfnhe expression levels. A statistically significant 30% decrease in QN IC(50) values was associated with these decreased expression levels in 1BB5 and 3BA6 but not in GC03. CQ, mefloquine and lumefantrine IC(50) values were unaltered. Cytosolic pH values were similar in all parental lines and recombinant clones. Our observations support a role for pfnhe in QN resistance in a strain-dependent manner, which might be contingent on pre-existing resistance to CQ and/or QN. These data bolster observations that QN resistance is a complex trait requiring the contribution of multiple transporter proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428659      PMCID: PMC3082771          DOI: 10.1016/j.molbiopara.2009.01.011

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  37 in total

Review 1.  Antimalarial drug resistance: the pace quickens.

Authors:  N J White
Journal:  J Antimicrob Chemother       Date:  1992-11       Impact factor: 5.790

2.  Plasmodium falciparum: a simple, rapid method for detecting parasite clones in microtiter plates.

Authors:  I D Goodyer; T F Taraschi
Journal:  Exp Parasitol       Date:  1997-06       Impact factor: 2.011

3.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Quinine and fever: The development of the effective dosage.

Authors:  D C Smith
Journal:  J Hist Med Allied Sci       Date:  1976-07       Impact factor: 2.088

5.  Dissecting the loci of low-level quinine resistance in malaria parasites.

Authors:  Michael T Ferdig; Roland A Cooper; Jianbing Mu; Bingbing Deng; Deirdre A Joy; Xin-zhuan Su; Thomas E Wellems
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

6.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.

Authors:  S K Martin; A M Oduola; W K Milhous
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

7.  Kinetic characterization of Na+/H+ antiport of Plasmodium falciparum membrane.

Authors:  A Bosia; D Ghigo; F Turrini; E Nissani; G P Pescarmona; H Ginsburg
Journal:  J Cell Physiol       Date:  1993-03       Impact factor: 6.384

8.  Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter.

Authors:  Karena L Waller; Rebecca A Muhle; Lyann M Ursos; Paul Horrocks; Dominik Verdier-Pinard; Amar Bir Singh Sidhu; Hisashi Fujioka; Paul D Roepe; David A Fidock
Journal:  J Biol Chem       Date:  2003-06-17       Impact factor: 5.157

9.  Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross.

Authors:  T E Wellems; L J Panton; I Y Gluzman; V E do Rosario; R W Gwadz; A Walker-Jonah; D J Krogstad
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

10.  Identification and localization of ERD2 in the malaria parasite Plasmodium falciparum: separation from sites of sphingomyelin synthesis and implications for organization of the Golgi.

Authors:  H G Elmendorf; K Haldar
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

View more
  33 in total

1.  Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.

Authors:  Stéphane Pelleau; Lionel Bertaux; Sébastien Briolant; Michael T Ferdig; Véronique Sinou; Bruno Pradines; Daniel Parzy; Ronan Jambou
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

Review 2.  How can we identify parasite genes that underlie antimalarial drug resistance?

Authors:  Tim Anderson; Standwell Nkhoma; Andrea Ecker; David Fidock
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

3.  Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.

Authors:  Frederick N Baliraine; Samuel L Nsobya; Jane Achan; James K Tibenderana; Ambrose O Talisuna; Bryan Greenhouse; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

4.  In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger.

Authors:  Hao Meng; Rongping Zhang; Henglin Yang; Qi Fan; Xinzhuan Su; Jun Miao; Liwang Cui; Zhaoqing Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

Review 5.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

6.  Polymorphisms in Pfmdr1, Pfcrt, and Pfnhe1 genes are associated with reduced in vitro activities of quinine in Plasmodium falciparum isolates from western Kenya.

Authors:  Jelagat Cheruiyot; Luicer A Ingasia; Angela A Omondi; Dennis W Juma; Benjamin H Opot; Joseph M Ndegwa; Joan Mativo; Agnes C Cheruiyot; Redemptah Yeda; Charles Okudo; Peninah Muiruri; Ngalah S Bidii; Lorna J Chebon; Paul O Angienda; Fredrick L Eyase; Jacob D Johnson; Wallace D Bulimo; Ben Andagalu; Hoseah M Akala; Edwin Kamau
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

7.  Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.

Authors:  Valérie Andriantsoanirina; Didier Ménard; Stéphane Rabearimanana; Véronique Hubert; Christiane Bouchier; Magali Tichit; Jacques Le Bras; Rémy Durand
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

Review 8.  In vitro selection of Plasmodium falciparum drug-resistant parasite lines.

Authors:  Alexis Nzila; Leah Mwai
Journal:  J Antimicrob Chemother       Date:  2009-12-18       Impact factor: 5.790

9.  Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Authors:  Véronique Parquet; Maud Henry; Nathalie Wurtz; Jerome Dormoi; Sébastien Briolant; Marine Gil; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

Review 10.  Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.

Authors:  Paul D Roepe
Journal:  Future Microbiol       Date:  2009-05       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.